UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 346

Sortiert nach

How I treat patients who mobilize hematopoietic stem cells poorly

Blood, 2011-10, Vol.118 (17), p.4530-4540

2011

Volltextzugriff (PDF)

Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo

Haematologica (Roma), 2021-12, Vol.106 (12), p.3176

2021

Volltextzugriff (PDF)

Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research

Leukemia, 2012-05, Vol.26 (5), p.1091-1097

2012

Volltextzugriff (PDF)

HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1

Cancer research (Chicago, Ill.), 2017-10, Vol.77 (20), p.5452-5463

2017

Volltextzugriff (PDF)

Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications

Clinical cancer research, 2008-06, Vol.14 (12), p.3881-3888

2008

Volltextzugriff (PDF)

An optimized algorithm for detecting and annotating regional differential methylation

BMC bioinformatics, 2013-04, Vol.14 Suppl 5 (Suppl 5), p.S10-S10, Article S10

2013

Volltextzugriff (PDF)

Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia

Nature genetics, 2011-10, Vol.43 (10), p.1012-1017

2011

Volltextzugriff (PDF)

Therapeutic concentrations of dasatinib inhibit in vitro osteoclastogenesis

Leukemia, 2009-05, Vol.23 (5), p.994-997

2009

Volltextzugriff (PDF)

Human Gastrointestinal Neoplasia‐Associated Myofibroblasts Can Develop from Bone Marrow‐Derived Cells Following Allogeneic Stem Cell Transplantation

Stem cells (Dayton, Ohio), 2009-06, Vol.27 (6), p.1463-1468

2009

Volltextzugriff (PDF)

Long-term imatinib therapy promotes bone formation in CML patients

Blood, 2008-03, Vol.111 (5), p.2538-2547

2008

Volltextzugriff (PDF)

GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations

Leukemia, 2013-07, Vol.27 (7), p.1588-1592

2013

Volltextzugriff (PDF)

Targeted Disruption of the CXCL12/CXCR4 Axis Inhibits Osteolysis in a Murine Model of Myeloma‐Associated Bone Loss

Journal of bone and mineral research, 2009-07, Vol.24 (7), p.1150-1161

2009

Volltextzugriff (PDF)

Cotransplantation of Placental Mesenchymal Stromal Cells Enhances Single and Double Cord Blood Engraftment in Nonobese Diabetic/Severe Combined Immune Deficient Mice

Stem cells (Dayton, Ohio), 2009-09, Vol.27 (9), p.2293-2300

2009

Volltextzugriff (PDF)

Measurement of In Vivo BCR-ABL Kinase Inhibition to Monitor Imatinib-Induced Target Blockade and Predict Response in Chronic Myeloid Leukemia

Journal of clinical oncology, 2007-10, Vol.25 (28), p.4445-4451

2007

Volltextzugriff (PDF)

Imatinib as a potential antiresorptive therapy for bone disease

Blood, 2006-06, Vol.107 (11), p.4334-4337

2006

Volltextzugriff (PDF)

Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML

Blood, 2009-11, Vol.114 (23), p.4859-4870

2009

Volltextzugriff (PDF)

Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis

Blood, 2015-04, Vol.125 (17), p.2649-2655

2015

Volltextzugriff (PDF)

Dynamic evolution of clonal epialleles revealed by methclone

Genome biology, 2014-09, Vol.15 (9), p.472-472, Article 472

2014

Volltextzugriff (PDF)

Dynamic assessment of RBC‐transfusion dependency improves the prognostic value of the revised‐IPSS in MDS patients

American journal of hematology, 2017-06, Vol.92 (6), p.508-514

2017

Volltextzugriff (PDF)

Mobilisation strategies for normal and malignant cells

Pathology, 2011-10, Vol.43 (6), p.547-565

2011

Volltextzugriff (PDF)

Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development in vivo

Experimental cell research, 2015-03, Vol.332 (1), p.24-38

2015

Volltextzugriff (PDF)

In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML

Blood, 2005-10, Vol.106 (7), p.2520-2526

2005

Volltextzugriff (PDF)

Tumor Angiogenesis Is Associated with Plasma Levels of Stromal-Derived Factor-1α in Patients with Multiple Myeloma

Clinical cancer research, 2006-12, Vol.12 (23), p.6973-6977

2006

Volltextzugriff (PDF)

Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells

Blood, 1998-01, Vol.91 (2), p.630-640

1998

Volltextzugriff (PDF)

A phase I study of the GM-CSF antagonist E21R

Cancer chemotherapy and pharmacology, 2002-09, Vol.50 (3), p.171-178

2002

Volltextzugriff (PDF)

1 – 25 von 346

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(319)
Mit Volltextzugriff
(323)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(228)
Life Sciences & Biomedicine
(184)
Humans
(155)
Female
(100)
Biological And Medical Sciences
(88)
Male
(87)
Adult
(77)
Medical Sciences
(74)
Middle Aged
(62)
Hematology
(39)
Aged
(36)
Physical Sciences
(36)
Animals
(34)
Oncology
(31)
Astronomy & Astrophysics
(30)
Endocrinology & Metabolism
(27)
Adolescent
(23)
Fundamental And Applied Biological Sciences. Psychology
(21)
Hematologic And Hematopoietic Diseases
(20)
Pharmacology. Drug Treatments
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

How I treat patients who mobilize hematopoietic stem cells poorly

Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo

Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research

HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1

Dasatinib Cellular Uptake and Efflux in Chronic Myeloid Leukemia Cells: Therapeutic Implications

An optimized algorithm for detecting and annotating regional differential methylation

Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia

Therapeutic concentrations of dasatinib inhibit in vitro osteoclastogenesis

Human Gastrointestinal Neoplasia‐Associated Myofibroblasts Can Develop from Bone Marrow‐Derived Cells Following Allogeneic Stem Cell Transplantation

Long-term imatinib therapy promotes bone formation in CML patients

GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations

Targeted Disruption of the CXCL12/CXCR4 Axis Inhibits Osteolysis in a Murine Model of Myeloma‐Associated Bone Loss

Cotransplantation of Placental Mesenchymal Stromal Cells Enhances Single and Double Cord Blood Engraftment in Nonobese Diabetic/Severe Combined Immune Deficient Mice

Measurement of In Vivo BCR-ABL Kinase Inhibition to Monitor Imatinib-Induced Target Blockade and Predict Response in Chronic Myeloid Leukemia

Imatinib as a potential antiresorptive therapy for bone disease

Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML

Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis

Dynamic evolution of clonal epialleles revealed by methclone

Dynamic assessment of RBC‐transfusion dependency improves the prognostic value of the revised‐IPSS in MDS patients

Mobilisation strategies for normal and malignant cells

Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development in vivo

In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML

Tumor Angiogenesis Is Associated with Plasma Levels of Stromal-Derived Factor-1α in Patients with Multiple Myeloma

Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells

A phase I study of the GM-CSF antagonist E21R

Suchergebnisse filtern